![一种复方药物组合物](/CN/2013/1/50/images/201310254649.jpg)
基本信息:
- 专利标题: 一种复方药物组合物
- 申请号:CN201310254649.1 申请日:2013-06-15
- 公开(公告)号:CN103301100B 公开(公告)日:2018-06-12
- 发明人: 常秀娟 , 苏慧芳 , 张永霞
- 申请人: 迪沙药业集团有限公司 , 威海迪素制药有限公司
- 申请人地址: 山东省威海市经济技术开发区青岛南路1号
- 专利权人: 迪沙药业集团有限公司,威海迪素制药有限公司
- 当前专利权人: 迪沙药业集团有限公司,迪嘉药业集团有限公司威海迪素制药有限公司
- 当前专利权人地址: 山东省威海市经济技术开发区青岛南路1号
- 主分类号: A61K31/19
- IPC分类号: A61K31/19 ; A61K31/495 ; A61K31/195 ; A61K31/4015 ; A61P25/08 ; A61K31/165
The invention relates to a composition for treating epilepsy, belonging to the technical field of medicines. The compound medicine composition for treating epilepsy is characterized in that the composition contains 3,4-dichlorophenyl-propenoyl-sec.-butylamine and a sodium channel blocker; the sodium channel blocker is selected from medicines such as valproic acid, flunarizine, gabapentin, ethosuximide and mesuximide; and unexpected synergistic effects are gained in treating epilepsy by carrying out compatibility on 3,4-dichlorophenyl-propenoyl-sec.-butylamine and the sodium channel blocker. The composition is provided to improve the compliance of patients and achieve the aim of controlling epileptic seizure, and simultaneously reduces the side effects of a clinical medicine of a central nervous system inhibitor. A safe and effective clinical medicine is provided for epilepsy patients.
公开/授权文献:
- CN103301100A 一种复方药物组合物 公开/授权日:2013-09-18
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K31/00 | 含有机有效成分的医药配制品 |
--------A61K31/045 | .羟基化合物,例如醇类;其盐类,例如醇化物 |
----------A61K31/19 | ..羧酸;例如丙戊酸 |